Global Pharmaceuticals & Biotech Big Green Snowflakes

Verrica Pharmaceuticals

Market Cap: US$47.2m

A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.

Larimar Therapeutics

Market Cap: US$331.2m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

Senti Biosciences

Market Cap: US$34.0m

A clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.

Y-mAbs Therapeutics

Market Cap: US$389.9m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

BioCryst Pharmaceuticals

Market Cap: US$1.7b

A biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases.

Terns Pharmaceuticals

Market Cap: US$660.7m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity.

Klaria Pharma Holding AB (publ.)

Market Cap: SEK 157.4m

A pharmaceutical company develops and commercializes medication for migraine and cancer related pain, and opioid overdose and anaphylactic shock.

Assembly Biosciences

Market Cap: US$360.2m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

NewAmsterdam Pharma

Market Cap: US$3.0b

A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.

Compugen

Market Cap: US$133.8m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

NextCell Pharma

Market Cap: SEK 120.7m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

Valbiotis

Market Cap: €12.9m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Black Diamond Therapeutics

Market Cap: US$185.0m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

EXACT Therapeutics

Market Cap: NOK 141.7m

A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).

Spyre Therapeutics

Market Cap: US$1.0b

A clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD).

Panion & Bf Biotech

Market Cap: NT$6.2b

A biotechnology pharmaceutical company, provides western medicines, cosmetics, and health care products in Taiwan, the United States, China, Hong Kong, and internationally.

RemeGen

Market Cap: HK$61.4b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States.

Imugene

Market Cap: AU$77.9m

A clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

Kwality Pharmaceuticals

Market Cap: ₹9.7b

Together with its subsidiary, manufactures, buys, sells, and deals finished pharmaceutical formulations in India and internationally.

Kilitch Drugs (India)

Market Cap: ₹5.8b

Engages in the development and operation of pharmaceutical business in India, Asia, Africa, Latin America, and Commonwealth of Independent States.

Amwill Health Care

Market Cap: ₹1.2b

A derma-cosmetic company, engages in the development and contract manufacturing of generic dermatological solutions in India.

Shukra Pharmaceuticals

Market Cap: ₹11.7b

Develops, manufactures, markets, and exports various drugs and dosage forms in India and internationally.

Shandong Jincheng Pharmaceutical Group

Market Cap: CN¥8.1b

Researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally.

Alzinova

Market Cap: SEK 133.5m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

4basebio

Market Cap: UK£132.3m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

Amicus Therapeutics

Market Cap: US$2.4b

A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.

Eurobio Scientific Société anonyme

Market Cap: €253.4m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

Cullinan Therapeutics

Market Cap: US$403.5m

A clinical-stage biopharmaceutical company, develops therapies for autoimmune diseases and cancer in the United States.

Compass Therapeutics

Market Cap: US$597.1m

A clinical-stage oncology-focused biopharmaceutical company, engages in the development of antibody-based therapeutics for the treatment of various human diseases in the United States.

Cinclus Pharma Holding

Market Cap: SEK 708.3m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

Arcellx

Market Cap: US$4.0b

Together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States.

Fortress Biotech

Market Cap: US$106.8m

A biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.

Philogen

Market Cap: €943.8m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

SCYNEXIS

Market Cap: US$40.2m

A biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States.

Indivior

Market Cap: US$3.1b

Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.

Mereo BioPharma Group

Market Cap: US$289.6m

A biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.